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Abstract
Talc isa commonir usea sc erosviQ aeon I forpleurode
s/s However there have been recent reports of a
numoer of con)o/icateons associateo u7tt3trre use ct
talc. A/though t/crc iS significant data regarding the
respiratory complications associated with talc, reports
ofbleeding come//cations are extremely rare. We pres
ent the case of a 78 year-old man who was treated
with ta/c pleurodesis for recurrent pleural effusion and
subsequently developed a massive hemothorax, a
rare complication.
Introduction
Management of idiopathic pleural effusion is a con
troversial topic. The effusion may resole spontane
ouslv or be treated with pleurodesis. Talc pleurodesis
is a commonly employed technique for the treatment
of spontaneous pneumothorax and recurrent pleural
effusion. The use of talc as an agent for pleurodesis
is ascribed to Bethune, who used it in preparation for
lung lobectomy in 1935.’ Due to impurities associated
with earlier preparations of talc, tetracycline was the
agent of choice in the United States until the 1980’s
when its production was discontinued for commercial
reasons. As tighter quality control was placed on the
production of talc. its popularity increased making itthe
agent of choice ft)r chemical pleurodesii. Preference
for talc as a sclerosing agent is based upon its cost.
availability, ease of use. and effectiveness in creating
pleural adhesions.” Regardless of its high degree of
effectiveness, talc is not the perfect sclerosmg agent
for pleuroclesis. Its use is associated with a number
of complications. We present a case of hemothorax
following tale pleurodesis in an elderly male treated
for idiopathic, recurrent pleural effusion,
Case Report
A78 year-old Japanese-American man w itha30-pack-
year history of smoking, asbestos exposure, coronary
artery disease with two coronary arter bypass grafts
CABGv h\ pertension. diabetes and intermittent
swelling of his lower extremities was stable in his
usual state of health until the day of admission, when
he presented to his primary care ph sician for recular
checkup. Upon examination, his ital signs were
within normal limits. 1-Ic was noted to ha e crackles
and diminished breath sounds over his right lung
field as well as bilateral pitting edema extending up
to his knees. Chest x-ray (CXR) revealed right-sided
pleural effusion filling half of the lung field, and the
patient was subsequently admitted. Laboratory stud
ies revealed: hemoglobin 10.3 g/dL. hematoerit 30%,
platelet 136,000/mm sodium 126 mEq/L,total protein
5.5 g/dL, and albumin 5.0 g/dL. Cardiac enzymes
and urinalysis were hcth \vithin normal limits. Furo—
semide was started on admission. and pitting edema
subsequently resolved. Echocardiograni showed
normal ejection fraction and left ventricular wall mo—
(ion. Follow up CXR was performed on the second
hospital day and showed no improvement in pleural
effusion (Fig U. On the third hospital day one liter of
yellow, turbid fluid was removed by thoracentesis and
analysis revealed: pH 7.5 13. RBC 33731mm’. WBC
110/mm3with 81 % neutrophils and 10% lymphocytes,
glucose ill mg/dl. LDH 105 U/L, protein 3.3 g/dl.
pretein fluid/serum ratio of 0.56, with the presence of
histiocytes, mesothelial cells, and lymphocytes. Gram
stain and culture of the fluid were negative.
On hospital day 5. CXR revealed reaccumulation
of effusion and aspirin was discontinued. On hospital
day 7. his PTT. PT. and INR were 38 sec. 12.3 sec.
and 1 .2 respectively. The patient underwent ideo
assisted thoracoscop (VATS) that revealed diffuse.
fibrotic, whitish plaques in his parietal pleura. and a
small posterior pleural mass. Biopsy of the pleural
plaques and the mass showed numerous hvperplastic
mesothelial cells admixed with fibrin Malignancy was
not identified. Twelve grams of talc was insuffiated
throughout the pleural surfaces to produce pleurode
sis. The morning after the procedure, the patient was
noted to have a temperature of 100.7 “F, blood pressure
of 90/40, and altered mental status. Arterial blood
gas revealed: pH 7.395. P0. 60 mmHg, PCO, 42.6
mmFlg, HCO: 2ft4 mmoliL.. BE 2. and SaO, S6.6H
on 2L oxYgen. Hemoglobin dropped to 8.5 g dL. but
returned to baseline of It) g, dL after transfusion of
four unit.s of packed red blood cells. Chest tube was
left in place for three da s and a total of 500 ml of
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sanguineous fluid was collected. On day 7 CBC re
vealed white cell count of 11 .000 with 57ff segmented
neutrophils and 32ff hands Afterremoval of the chest
tube the patient was noted to have diminished breath
sounds on the right and recurrence of effusion \cas
suspeetedthus aCTscan was performed and revealed
a massive heterogeneous effusion in his right thorax.
suepestive of eit.her a hematom.a or ernpvema 1 H.
71 On %pitai day l 7, right th.oraeotomv s.h owed
lied and sea.rred parletal. uleura and d ffuse he in
un3tme ice ml leura. Donna the proeedurc_ ‘-U ii
ml ut elotted blood ras e-vaeuated trout the pleural
isa wotent develo ad acute respitsiars Li! lute
and reautred mechanical eutilation
in tile lC LI Chest s-mu revealed reaeeurnulattott of
I ntrathoraete and subcutaneous het nan una’
-f total of I 300 ml of sauzuineous fluid sva’ drained
Crouch tOe chest tube. and several units of packad
red blood cells fresh Cozen lasitia. and latelet
0 eta- transtused. On hospital Civ Sl the patient Is as
tninsterre—d to a skilled riursinc faeilitr %r rehahlita—
Discussion
Chemical pleurodesis involves the niroduetion of a
elerosine agent into the pleural space inducing fusion
ot the visceral and parietal pleura to prevent recur
rence of pneumothorax or pleural effusion. Currently,
tale is the agent of choice for producing pleurodesis
n the [nited States. Tale is thought to produce
pleural adhesions by stimulating a local inflamma
tory response. causing mesothehal cell injur and
tibroblastic proliferation, and decreasing Ii hrinol\ tic
activity.5-6Several studies have found tale’s abilit\
to produce adhesion to he equal or superior to other
selerosants.ss Although talc is believed to he one
of the safest, cheapest, and most effective agents for
promoting pleural adhesion, there are a number of
reported complications.
Minor complications such as taehycardia (33%),5
fever (2.8-24% %tm0L0 and dyspnea (7-1 2%)° have
been observed. Hypoxia and hypotension have also
been reported with eases ranging between 101 2%.
and 1-12% respectively,°-°-5Other major compli
cations that have been reported inc lode prolonged
drainage (4%)J airleaks (0.1-2.4%).”5re-expansion
pulmonary edema (2.2 - I 2.3%),012 empyema (I .2
and acute respiratory distress syndrome
I 3( 9%)
Our patient had similar complications including
lever. hpoxia. and hypotension. He also des eloped
hemorrhagic pleuritis, which has not been extenivelr
discussed in the literature We conducted a Medlinc
literature search, limited to English language and
found unIv three reports of bleeding complications
assoeiatedw ith talc pleurodesis. One retrospeetis e
study showed that of 85 ptitieilts undergoing talc
pleurodesis. unIv one des eloped postoperative bleed-
ing, Another study by Cardillo et al reported that I out of 69(1 patients developed
hemorrhagic complications.0The third study reported that 2 out of 614 patients
developed postoperative bleeding.° None of these three studies discussed the
bleeding complication in detail.
The exact cause of the hemorrhagic pleuritis in our patient is unknown. We be
lies e that this patient’s coagulation profile, asbestos exposure. and pleural biopsy
did not directly contribute to his post—operative bleeding. (‘oagulopathv was not a
major concern in this patient since he did not develop postoperatis e bleeding ss ith
his pres ious CABG surgeries. The patient had no histor of ss arfarin use, his PT
and INR were within normal limits, and aspirin ss as discontinued tss o dar s prior
to surgers. Exposure to asbestos may have contributed to this patient’s pleural
effusion. Ilowever. it does not seem to he solel responsible for the hemorrhagic
pleuritis. Diffuse, fibrotic. whitish plaques consistent with pres ious asbestos
exposure ss crc noted on the parietal pleura during VATS. Hos es er at the time of
thoraeotomv on hospital das 17. bleeding was observed from the iseeral pleura.
and not the parietal pleura. In addition, Aelons el al did not observe hemorrhagic
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complications in three patients with asbestosis injury who underwent talc pleurode
sisi7 Since the bleeding in this patient came from the visceral pleura, the biopsy,
which was performed on the parietal pleura, did not contribute to this patient’s
bleeding complication. The safety of video-assisted thoracoscopic pleural biopsy
is supported by the study by Allen et al, which demonstrated no postoperative
bleeding complications in 6 patients who underwent the procedure)3
Possible causes of hemorrhagic complications are the talc itself, the method
of talc application, and the amount of talc used. Although one animal study
demonstrated that intrapleural talc administration does not cause hemothorax.
several other studies suggest that talc could cause damage predisposing a patient
to hemorrhagic complications.S Studies in rabbits and rats have shown that talc
distributes systemically after intrapleural administration. In another study. an
autopsy of a patient who died from acute respiratory distress syndrome showed
talc particles deposited in ipsilateral and contralateral lung. brain, liver, kidney.
heart, spleen. and skeletal muscle) Thus. talc particles could hae entered the
circulation and caused damage to the vascular endothelium resulting in bleeding
complications.
Talc delivered b insufflation may contribute to hemorrhagic pleuritis. Our
patient and two other reported cases developed postoperative bleeding after talc
insufflation. The method of talc delivers is unknown in anothercase mentioned
by Allen et al. In contrast, an animal study comparing anatomic and histopatho—
logic results of four different methods ofpleurodesis including thoracoscopic talc
insuftiation. talc slurry abrasion, focal gauze abrasion b limited thoracotoms. and
mechanical abrasion by thorascopv. observed no hemorrhagic complications.’
Hosever. the studs ‘ sample site of 10 may have been too small to observe any
bleeding complications.
Lastly, the amountof talc used may pla a role in the developmentofthe bleeding
complication. Our patient had 12 grams of talc insufflated to achiee pleurodesis.
Hoxever. postoperative bleedings have been reported at different doses. Bleeding
complications s crc reported in Milanez et al’s study, which used only 2 grams of
talc, The study by (‘ardillo who reported one case of postoperative bleeding used
5 grams of talc. 5 The amount of talc used is unknown in the study conducted bx
Allen et al. who reported one case of postoperative bleeding. Rehse et al used It>
grams of talc slurry and they (lid not observe any postoperative bleeding.’° Since
the occurrence of bleeding complications varies with different doses of talc, it
is unclear s’. hethcr the I 2 grams of talc used for this
patient is dircctl responsible for the dc clopmcnt of
he morrh aoi c pie a riti s,
Conclusion
1_sing tale as a se lerosine a.enr Pr pleuiodcsis is
comntonh accepted practice In thts case i cport.
cai —old man w ho nnderss cnt thora rscopiL Lilt
plcun dcsis dc eloped massic . ol cdin. P istopt. i a
tis c bleeding is a rare eornplt ‘ttiofl itt 11 1 irodcsis
\lthoueh the exact mcchanisn I ‘tWo L this patient
inassib e hcmorrhaee rem tins nkno so th tiolos
is most likels malt f to i’ It ma h th t ilr
itself the methodottal ‘ippli ‘ot s. n andt m an
talL used. Our patient s oWes c p0 a and by htl
piolonged PT INR rc p oh’ bly of I 5 import’ nc
\Ithoueh talc cfheac and ommon comphea ion
are ss cli do un nt ‘d it is import tnt to onsider po
opei atib bI edin as a possible c. r compli ation
Further studies at needed to better understand the
safety and complications oi talc pleurod si
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